Guaifenesin Tablet, Extended Release
FDA Label NDC 58602-810

15 label sections · Submitted to the FDA by Aurohealth Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Aurohealth Llc for the product Guaifenesin (NDC 58602-810). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient

(in each extended-release tablet)
 Guaifenesin USP 600 mg

Purpose

Expectorant

Uses


  • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

Warnings

Do not use


  • for children under 12 years of age

Ask A Doctor Before Use If You Have


  • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
  • cough accompanied by too much phlegm (mucus)

Stop Use And Ask A Doctor If


  • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.

If Pregnant Or Breast-Feeding,

ask a health professional before use

Keep Out Of Reach Of Children.

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

  • do not crush, chew, or break extended-release tablet
  • take with a full glass of water
  • this product can be administered without regard for the timing of meals
  • adults and children 12 years of age and over: 1 or 2 extended-release tablets every 12 hours. Do not exceed 4 extended-release tablets in 24 hours
  • children under 12 years of age: do not use

Other Information

  • store between 20° to 25°C (68° to 77°F)

Inactive Ingredients


colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, povidone, and pregelatinised starch (maize)

Questions?

1-855-274-4122 (Monday – Friday 8:30 AM to 5:00 PM EST)


Distributed by:
AUROHEALTH LLC.
279 Princeton-Hightstown Road,
East Windsor, NJ 08520

Made in India
 

Package Label-Principal Display Panel - 600 Mg (20 Tablet Label)

AUROHEALTH

NDC 58602-810-73

Guaifenesin
Extended-Release
Tablets 600 mg

Guaifenesin
600 mg- Expectorant

RELIEVES CHEST CONGESTION

12
HOUR

  • Relieves Chest Congestion
  • Thins & Loosens Mucus
  • 20 Extended-Release Tablets

    Package Label-principal Display Panel (600 mg (20 Tablet Label))

    Package Label-principal Display Panel (600 mg (20 Tablet Label))



Package Label-Principal Display Panel - 600 Mg (20 Tablet Carton Label)

AUROHEALTH

NDC 58602-810-73

Compare to the active
ingredient in Mucinex®*

Guaifenesin
Extended-Release Tablets 600 mg

Guaifenesin 600 mg - Expectorant

RELIEVES CHEST CONGESTION
 
•Relieves Chest Congestion
•Thins & Loosens Mucus

12
HOUR 

Actual size

20 Extended-Release
Tablets

Package Label-principal Display Panel (600 mg (20 Tablet Carton Label))

Package Label-principal Display Panel (600 mg (20 Tablet Carton Label))


Package Label-Principal Display Panel - 600 Mg Blister Carton (20 (1 X 20) Tablets)

AUROHEALTH

NDC 58602-810-96

Compare to the active
ingredient in Mucinex®*

Guaifenesin
Extended-Release Tablets 600 mg

Guaifenesin 600 mg - Expectorant

RELIEVES CHEST CONGESTION
 
•Relieves Chest Congestion
•Thins & Loosens Mucus

Actual size

20
Extended-Release Tablets

12
HOUR 


Package Label-principal Display Panel (600 mg Blister Carton (20 (1 x 20) Tablets))

Package Label-principal Display Panel (600 mg Blister Carton (20 (1 x 20) Tablets))

* Please review the disclaimer below.